Summary
Transforming growth factor-alpha (TGFα)-pseudomonas exotoxin-40 (PE40) is a chimeric protein consisting of an N-terminal TGFα domain fused to a C-terminal 40-kDa segment of the pseudomonas exotoxin A protein. TGFα-PE40 exhibits the receptor binding activity of TGFα and the cell killing activity of PE40. In the current study, we report that a modified TGFα-PE40 derivative significantly prolongs the survival of nude mice bearing tumors derived from cell lines which express the epidermal growth factor receptor (EGFR). In addition, the therapeutic benefit of this protein is mediated by specific binding to the EGF receptor. These results indicate that a therapeutic window exists in vivo for the use of some growth factor-toxin fusion proteins as anticancer agents.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Chaudhary, V.K., D.J. Fitzgerald, S. adhya, and I. Pastan. 1987. Activity of a recombinant fusion protein between transforming growth factor type-alpha and pseudomonas toxin. Proc. Natl. Acad. Sci. USA 84: 4538–4542.
Edwards, G.M., D. DeFeo-Jones, J.Y. Tai, G.A. Vuocolo, D.R. Patrick, D.C. Heimbrook, and A. Oliff. 1989. Epidermal growth factor receptor binding is affected by structural determinants in the toxin domain of transforming growth factor alpha-pseudomonas exotoxin fusion proteins. Mol. Cell. Biol. 9: 2860–2867.
Iglewski, B.H., and D. Kabat. 1975. NAD-Dependent inhibition of protein synthesis byPseudomonas aeruginosa exotoxin. Proc. Natl. Acad. Sci. USA. 72: 2284–2288.
Pastan, I., and D. FitzGerald. 1989.Pseudomonas exotoxin: Chimeric toxins. J. Biol. Chem. 264: 15157–15160.
Proper, J.A., C.L. Bjornson, and H.L. Moses. 1982. Mouse embryos contain polypeptide growth factor(s) capable of inducing reversible neoplastic phenotype in nontransformed cells in culture. J. Cell Physiol. 110: 169–174.
Stoscheck, C.M., and L.E. King. 1986. Functional and structural characteristics of EGF and its receptor and their relationship to transforming proteins. J. Cell. Biochem. 31: 135–152.
Yeh, J., and Y.-C. Yeh. 1989. Role of epidermal growth factor in carcinogenesis. Biomed. Pharmacother. 43: 651–660.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heimbrook, D.C., Stirdivant, S.M., Ahern, J.D. et al. Biological activity of a transforming growth factor-alpha-Pseudomonas exotoxin fusion protein in vitro and in vivo. Journal of Industrial Microbiology 7, 203–207 (1991). https://doi.org/10.1007/BF01575884
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01575884